p.72 抽出テキスト

CLINICAL STATEMENTS AND GUIDELINES

June 11, 2024 Circulation. 2024;149:e1313–e1410. DOI: 10.1161/CIR.0000000000001251 e1384

10 McDermott MM, Polonsky TS, Kibbe MR, et al. Racial differences in func-

tional decline in peripheral artery disease and associations with socioeconomic status and education. J Vasc Surg. 2017;66:826–834. 11.	 Fanaroff AC, Yang L, Nathan AS, et al. Geographic and Socioeconomic Disparities in Major Lower Extremity Amputation Rates in Metropolitan Areas. J Am Heart Assoc. 2021;10:e021456. 12.	 Selvin E, Erlinger TP. Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000. Circulation. 2004;110:738–743. 13.	 Hackler EL 3rd, Hamburg NM, White Solaru KT. Racial and ethnic disparities in peripheral artery disease. Circ Res. 2021;128:1913–1926. 14.	 Geronimus AT, Hicken M, Keene D, et al. “Weathering” and age patterns of allostatic load scores among blacks and whites in the United States. Am J Public Health. 2006;96:826–833. 15.	 Churchwell K, Elkind MSV, Benjamin RM, et al. Call to action: structural racism as a fundamental driver of health disparities: a presidential advisory from the American Heart Association. Circulation. 2020;142:e454–e468. 16.	 Williams DR. Race, socioeconomic status, and health. The added effects of racism and discrimination. Ann N Y Acad Sci. 1999;896:173–188. 17.	 Creager MA, Matsushita K, Arya S, et al. Reducing nontraumatic lowerextremity amputations by 20% by 2030: time to get to our feet: a policy statement from the American Heart Association. Circulation. 2021;143:e875–e891. 18.	 Centers for Disease Control and Prevention. About underlying cause of death, 1999-2020. Accessed February 15, 2023. https://wonder.cdc.gov/ ucd-icd10.html. 19.	 Grines CL, Klein AJ, Bauser-Heaton H, et al. Racial and ethnic disparities in

coronary, vascular, structural, and congenital heart disease. Catheter Cardiovasc Interv. 2021;98:277–294. 4.2.1. Race and Ethnicity 1.	 Hackler EL 3rd, Hamburg NM, White Solaru KT. Racial and ethnic disparities in peripheral artery disease. Circ Res. 2021;128:1913–1926. 2.	 Allison MA, Armstrong DG, Goodney PP, et al. Health disparities in peripheral artery disease: a scientific statement from the American Heart Association. Circulation. 2023;148:286–296. 3.	 Matsushita K, Sang Y, Ning H, et al. Lifetime risk of lower-extremity peripheral artery disease defined by ankle-brachial index in the United States. J Am Heart Assoc. 2019;8:e012177. 4.	 Criqui MH, Matsushita K, Aboyans V, et al. Lower extremity peripheral artery disease: contemporary epidemiology, management gaps, and future directions: a scientific statement from the American Heart Association. Circulation. 2021;144:e171–e191. 5.	 Allison MA, Cushman M, Solomon C, et al. Ethnicity and risk factors for change in the ankle-brachial index: the Multi-Ethnic Study of Atherosclerosis. J Vasc Surg. 2009;50:1049–1056. 6.	 Demsas F, Joiner MM, Telma K, et al. Disparities in peripheral artery disease care: A review and call for action. Semin Vasc Surg. 2022;35:141–154. 7.	 Arya S, Binney Z, Khakharia A, et al. Race and socioeconomic status independently affect risk of major amputation in peripheral artery disease. J Am Heart Assoc. 2018;7:e007425. 8.	 Krawisz AK, Natesan S, Wadhera RK, et al. Differences in comorbidities explain black-white disparities in outcomes after femoropopliteal endovascular intervention. Circulation. 2022;146:191–200. 9.	 Soden PA, Zettervall SL, Deery SE, et al. Black patients present with more severe vascular disease and a greater burden of risk factors than white patients at time of major vascular intervention. J Vasc Surg. 2018;67:549– 556.e3. 10.	 Gober L, Bui A, Ruddy JM. Racial and gender disparity in achieving optimal medical therapy for inpatients with peripheral artery disease. Ann Vasc Med Res. 2020;7:1115. 11.	 Meadows TA, Bhatt DL, Hirsch AT, et al. Ethnic differences in the prevalence and treatment of cardiovascular risk factors in US outpatients with peripheral arterial disease: insights from the reduction of atherothrombosis for continued health (REACH) registry. Am Heart J. 2009;158:1038–1045. 12.	 Divakaran S, Carroll BJ, Chen S, et al. Supervised exercise therapy for symptomatic peripheral artery disease among Medicare beneficiaries between 2017 and 2018: participation rates and outcomes. Circ Cardiovasc Qual Outcomes. 2021;14:e007953. 13.	 Rucker-Whitaker C, Greenland P, Liu K, et al. Peripheral arterial disease in African Americans: clinical characteristics, leg symptoms, and lower extremity functioning. J Am Geriatr Soc. 2004;52:922–930. 14.	 McDermott MM, Polonsky TS, Kibbe MR, et al. Racial differences in func-

tional decline in peripheral artery disease and associations with socioeconomic status and education. J Vasc Surg. 2017;66:826–834. 15 Barnes JA, Eid MA, Creager MA, et al. Epidemiology and risk of amputation

in patients with diabetes mellitus and peripheral artery disease. Arterioscler Thromb Vasc Biol. 2020;40:1808–1817. 16.	 Mustapha JA, Fisher BT Sr, Rizzo JA, et al. Explaining racial disparities in amputation rates for the treatment of peripheral artery disease (PAD) using decomposition methods. J Racial Ethn Health Disparities. 2017;4:784–795. 17.	 Carnethon MR, Pu J, Howard G, et al. Cardiovascular health in African Americans: a scientific statement from the American Heart Association. Circulation. 2017;136:e393–e423. 18.	 Lefebvre KM, Lavery LA. Disparities in amputations in minorities. Clin Orthop Relat Res. 2011;469:1941–1950. 19.	 Goodney PP, Dzebisashvili N, Goodman DC, Bronner KK. Variation in the Care of Surgical Conditions: Diabetes and Peripheral Arterial Disease: A Dartmouth Atlas of Health Care Series. The Dartmouth Institute for Health Policy and Clinical Practice; October 14, 2014. 20.	 Grines CL, Klein AJ, Bauser-Heaton H, et al. Racial and ethnic disparities in coronary, vascular, structural, and congenital heart disease. Catheter Cardiovasc Interv. 2021;98:277–294. 21.	 Dillingham TR, Pezzin LE, MacKenzie EJ. Limb amputation and limb deficiency: epidemiology and recent trends in the United States. South Med J. 2002;95:875–883. 22.	 Hirsch AT, Allison MA, Gomes AS, et al. A call to action: women and peripheral artery disease: a scientific statement from the American Heart Association. Circulation. 2012;125:1449–1472. 23.	 Durazzo TS, Frencher S, Gusberg R. Influence of race on the management of lower extremity ischemia: revascularization vs amputation. JAMA Surg. 2013;148:617–623. 24.	 Holman KH, Henke PK, Dimick JB, et al. Racial disparities in the use of revascularization before leg amputation in Medicare patients. J Vasc Surg. 2011;54:420–426, 426 e421. 25.	 Tunis SR, Bass EB, Klag MJ, et al. Variation in utilization of procedures for treatment of peripheral arterial disease. A look at patient characteristics. Arch Intern Med. 1993;153:991–998. 26.	 Holman KH, Henke PK, Dimick JB, et al. Racial disparities in the use of revascularization before leg amputation in Medicare patients. J Vasc Surg. 2011;54:420–426, 426.e1. 27.	 Mustapha JA, Fisher BT Sr, Rizzo JA, et al. Explaining racial disparities in amputation rates for the treatment of peripheral artery disease (PAD) using decomposition methods. J Racial Ethn Health Disparities. 2017;4:784–795. 28.	 Carr J. “Sprint to zero”: a strategy to address high rates of nontraumatic amputations in minority communities. Am J Manag Care. 2017;23:SP578- SP579. 29.	 Chen L, Zhang D, Shi L, et al. Disparities in Peripheral artery disease hospitalizations identified among understudied race-ethnicity groups. Front Cardiovasc Med. 2021;8:692236. 30.	 Morrissey NJ, Giacovelli J, Egorova N, et al. Disparities in the treatment and outcomes of vascular disease in Hispanic patients. J Vasc Surg. 2007;46:971–978. 31.	 Luna P, Harris K, Castro-Dominguez Y, et al. Risk profiles, access to care, and outcomes in Hispanics hospitalized for lower extremity peripheral artery disease. J Vasc Surg. 2023;77:216–224 e215. 32.	 Resnick HE, Valsania P, Phillips CL. Diabetes mellitus and nontraumatic lower extremity amputation in black and white Americans: the National Health and Nutrition Examination Survey Epidemiologic Follow-up Study, 1971-1992. Arch Intern Med. 1999;159:2470–2475. 33.	 Fanaroff AC, Yang L, Nathan AS, et al. Geographic and socioeconomic disparities in major lower extremity amputation rates in metropolitan areas. J Am Heart Assoc. 2021;10:e021456. 34.	 Creager MA, Matsushita K, Arya S, et al. Reducing nontraumatic lower-

extremity amputations by 20% by 2030: time to get to our feet: a policy statement from the American Heart Association. Circulation. 2021;143:e875–e891.

4.2.2 Female Sex 1.	 Hirsch AT, Allison MA, Gomes AS, et al. A call to action: women and periph-

eral artery disease: a scientific statement from the American Heart Association. Circulation. 2012;125:1449–1472. 2.	 Pabon M, Cheng S, Altin SE, et al. Sex differences in peripheral artery disease. Circ Res. 2022;130:496–511. 3.	 McDermott MM, Greenland P, Liu K, et al. Sex differences in peripheral arterial disease: leg symptoms and physical functioning. J Am Geriatr Soc. 2003;51:222–228. 4.	 Haine A, Kavanagh S, Berger JS, et al. Sex-specific risks of major cardiovas-

cular and limb events in patients with symptomatic peripheral artery disease. J Am Coll Cardiol. 2020;75:608–617.

Downloaded from http://ahajournals.org by on October 7, 2026